Income Taxes (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
| Income Tax Disclosure [Abstract] |
|
| Schedule of Domestic and Foreign Components of Loss Before Provision for Income Taxes on Continuing Operations |
The domestic and foreign components of loss before provision for income taxes on continuing operations were as follows: | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | 2025 | | 2024 | | 2023 | | Domestic | $ | (59,109) | | | $ | (33,156) | | | $ | (59,254) | | | Foreign | 2,161 | | | (138) | | | 5,144 | | | Total loss before income taxes | $ | (56,948) | | | $ | (33,294) | | | $ | (54,110) | |
|
| Schedule of Provision (Benefit) for Income Taxes On Continuing Operations |
The provision / (benefit) for income taxes on continuing operations consisted of the following: | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | 2025 | | 2024 | | 2023 | | Current provision / (benefit) | | | | | | | Federal | $ | (118) | | | $ | — | | | $ | — | | | State | (47) | | | 49 | | | 92 | | | Foreign | 462 | | | 956 | | | (1,689) | | | Total current provision / (benefit) | $ | 297 | | | $ | 1,005 | | | $ | (1,597) | | | Deferred provision / (benefit) | | | | | | | Federal | $ | (38) | | | $ | 1 | | | $ | 3 | | | State | (25) | | | 11 | | | (4) | | | Foreign | 152 | | | (355) | | | 3,200 | | | Total deferred provision / (benefit) | $ | 89 | | | $ | (343) | | | $ | 3,199 | | | Total provision / (benefit) | | | | | | | Federal | $ | (156) | | | $ | 1 | | | $ | 3 | | | State | (72) | | | 60 | | | 88 | | | Foreign | 614 | | | 601 | | | 1,511 | | | Total provision / (benefit) | $ | 386 | | | $ | 662 | | | $ | 1,602 | |
|
| Schedule of Reconciliation of the U.S. Statutory Income Tax Rate On Continuing Operations to the Company's Effective Tax Rate |
A reconciliation of the U.S. federal statutory income tax rate on continuing operations of 21% for the years ended December 31, 2025, 2024, and 2023 to the Company’s effective tax rate is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | | 2025 | | 2024 | | 2023 | | U.S. federal statutory tax rate | | $ | (11,959) | | 21.0 | % | | $ | (6,992) | | 21.0 | % | | $ | (11,363) | | 21.0 | % | State and local income taxes, net of federal income tax effect1 | | (116) | | 0.2 | % | | (704) | | 2.1 | % | | 198 | | (0.4) | % | | Foreign tax effects | | | | | | | | | | | Canada: | | | | | | | | | | | Other | | 183 | | (0.3) | % | | 209 | | (0.6) | % | | (83) | | 0.2 | % | | Other foreign jurisdictions | | | | | | | | | | | Foreign exchange impacts | | 364 | | (0.6) | % | | 325 | | (1.0) | % | | (218) | | 0.4 | % | | Change in valuation allowance | | (4,797) | | 8.4 | % | | (61) | | 0.2 | % | | (1,321) | | 2.4 | % | | Return to accrual | | 4,074 | | (7.2) | % | | (54) | | 0.2 | % | | 1,599 | | (3.0) | % | | Other | | 322 | | (0.6) | % | | 39 | | (0.1) | % | | 339 | | (0.6) | % | | Effects of cross-border tax laws | | — | | — | % | | — | | — | % | | 511 | | (0.9) | % | | Tax credits | | | | | | | | | | | Research and development credit | | — | | — | % | | (2,135) | | 6.4 | % | | — | | — | % | | Change in valuation allowance | | 5,964 | | (10.5) | % | | 8,266 | | (24.9) | % | | 9,526 | | (17.6) | % | | Nontaxable or non-deductible items | | | | | | | | | | | Stock-based compensation | | 75 | | (0.1) | % | | 228 | | (0.7) | % | | 2,137 | | (3.9) | % | | Goodwill impairment | | 6,342 | | (11.1) | % | | — | | — | % | | — | | — | % | | Loss on debt extinguishment | | 993 | | (1.7) | % | | — | | — | % | | — | | — | % | | Warrant and derivative liabilities | | (321) | | 0.6 | % | | 288 | | (0.9) | % | | (36) | | 0.1 | % | | Other non-taxable or non-deductible items | | 161 | | (0.3) | % | | 308 | | (0.9) | % | | 294 | | (0.5) | % | | Uncertain tax positions | | — | | — | % | | 2 | | — | % | | — | | — | % | | Other reconciling items | | | | | | | | | | | Return to accrual | | (881) | | 1.5 | % | | 802 | | (2.4) | % | | 231 | | (0.4) | % | | Other | | (18) | | — | % | | 141 | | (0.4) | % | | (212) | | 0.2 | % | | Total tax expense | | $ | 386 | | (0.7) | % | | $ | 662 | | (2.0) | % | | $ | 1,602 | | (3.0) | % | _____________________________ (1)For the year ended December 31, 2025, California made up greater than 50% of the effect of the U.S. state and local income tax category. For the years ended December 31, 2024, and 2023, California, New York, and New York City made up greater than 50% of the effect of the US. state and local income tax category.
|
| Schedule of Significant Components of Deferred Tax Assets and Deferred Tax Liabilities |
Significant components of deferred tax assets and liabilities as of December 31, 2025 and 2024 were as follows: | | | | | | | | | | | | | Year Ended December 31, | | 2025 | | 2024 | | Deferred tax assets | | | | | Net operating loss and tax credit carryforwards | $ | 89,768 | | | $ | 86,005 | | | Accruals | 1,461 | | | 2,191 | | | Depreciation and amortization | 720 | | | 283 | | | Stock-based compensation | 1,648 | | | 773 | | | Bad debt | 65 | | | 177 | | | | | | | Interest expense | 6,833 | | | 4,713 | | | Lease liabilities | 6,735 | | | 8,830 | | | Section 174 capitalized R&D costs | 8,227 | | | 9,328 | | | Capitalized production expenses | 156 | | | 213 | | | Other | 1,610 | | | 1,373 | | | Total deferred tax asset | $ | 117,223 | | | $ | 113,886 | | | Valuation allowance | (103,114) | | | (99,097) | | | Net deferred tax asset | $ | 14,109 | | | $ | 14,789 | | | | | | | Deferred tax liabilities | | | | | | | | | Operating lease, right-of-use asset | (5,647) | | | (6,778) | | | Intangible assets | (8,236) | | | (7,720) | | | Other | (24) | | | — | | | Total deferred tax liability | $ | (13,907) | | | $ | (14,498) | | | Net deferred tax asset | $ | 202 | | | $ | 291 | |
|
| Schedule of Cash Paid for Income Taxes, Net of Refunds |
The following table presents taxes paid by respective jurisdiction in excess of 5% of total income taxes paid, net of refunds received. | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | 2025 | | 2024 | | 2023 | | U.S. Federal | $ | 40 | | | $ | 673 | | | $ | — | | | U.S. state and local | | | | | | | California | 244 | | | 314 | | | (63) | | | | | | | | | | | | | | | Illinois | 119 | | | 129 | | | — | | | | | | | | | | | | | | | | | | | | | New York | 43 | | | 73 | | | 48 | | | New York City | 4 | | | 39 | | | 4 | | | Pennsylvania | 68 | | | 76 | | | 7 | | | All other | 204 | | | 271 | | | 130 | | | Total U.S. State and Local | 682 | | | 902 | | | 126 | | | Non-US | | | | | | | Australia | — | | | (32) | | | 131 | | | Canada | 146 | | | (1,142) | | | 896 | | | United Kingdom | 87 | | | — | | | — | | | Germany | 7 | | | 30 | | | — | | | India | — | | | — | | | 129 | | | Mexico | 31 | | | 72 | | | — | | | All Other | 19 | | | 11 | | | 14 | | | Total Non-U.S | 290 | | | (1,061) | | | 1,170 | | | Total cash income taxes paid, net | $ | 1,012 | | | $ | 514 | | | $ | 1,296 | |
| | | | | | | | | | | | | | | | | | | Year Ended December 31, | | 2025 | | 2024 | | 2023 | | Cash paid for income taxes, net | $ | 1,012 | | | $ | 514 | | | $ | 1,296 | | | Cash paid for interest | 3,921 | | | 11,926 | | | 17,169 | | | Non-cash investing and financing activities: | | | | | | | Debt assumed for acquisition of Girls Like Girls Film Inc. | 4,790 | | | — | | | — | | | Non-cash debt repaid against Girls Like Girls Film Inc. Indebtedness | 3,600 | | | — | | | — | | | Non-cash consideration from film financing arrangements | 500 | | | — | | | — | | | Non-cash debt repaid against film financing arrangements | 210 | | | — | | | — | | | Non-cash consideration from co-financing arrangements for feature films | 475 | | | — | | | — | | | Capitalized interest for film financing arrangements | 2,702 | | | — | | | — | | | Accrued debt issuance costs for Term Loan | 640 | | | — | | | — | | | Accounts payable and accrued expenses related to property and equipment | 292 | | | 31 | | | 134 | | | Accrued deferred offering costs | 67 | | | 68 | | | 597 | | | Exchange of accounts receivable in exchange for investment in equity securities | — | | | — | | | 750 | | | Non-cash contingent consideration for business combination | 424 | | | — | | | — | | | | | | | | | | | | | | | | | | | | | Reconciliation of cash and cash equivalents and restricted cash within the consolidated balance sheets to the amounts shown in the statement of cash flows: | | | | | | | Cash and cash equivalents | $ | 8,465 | | | $ | 22,373 | | | $ | 10,637 | | | Restricted cash | 15,750 | | | — | | | — | | | Noncurrent restricted cash | 3,524 | | | 16,275 | | | 25,000 | | | Total cash and cash equivalents and restricted cash | $ | 27,739 | | | $ | 38,648 | | | $ | 35,637 | |
|
| Schedule of Income Tax Examinations |
The earliest years’ tax returns filed by the Company that are still subject to examination by the tax authorities in the major jurisdictions are as follows: | | | | | | | Years | | United States | 2021 | | United Kingdom | 2022 | | Japan | 2020 | | Canada | 2021 |
|